clarithromycin has been researched along with Carcinoma in Situ in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, HS; Jung, DH; Kim, JH; Lee, SK; Lee, YC; Park, JC; Shin, SH; Shin, SK | 1 |
| Fox, JG; Ge, Z; Lee, CW; Rickman, B; Rogers, AB; Wang, TC | 1 |
2 other study(ies) available for clarithromycin and Carcinoma in Situ
| Article | Year |
|---|---|
Helicobacter pylori Eradication Prevents Metachronous Gastric Neoplasms after Endoscopic Resection of Gastric Dysplasia.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Carcinoma in Situ; Clarithromycin; Female; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Proton Pump Inhibitors; Retrospective Studies; Stomach; Stomach Neoplasms | 2015 |
Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice.
Topics: Animals; Anti-Infective Agents; Anti-Ulcer Agents; Carcinoma in Situ; Cell Proliferation; Clarithromycin; Disease Progression; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Interferon-gamma; Lithostathine; Male; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Omeprazole; Precancerous Conditions; Stomach Neoplasms; Stomach Ulcer; Tumor Necrosis Factor-alpha | 2008 |